Semisolid Matrix Filled Capsules: An Approach to Improve Dissolution Stability of Phenytoin Sodium Formulation

References

• Walker S.E., Granley J.A., Bedford K., Evans T. The filling of molten and thixotropic formulations into hard gelatin capsules. J. Pharm. Pharmacol. 1980; 32: 389–392
   PubMed Web of Science ®Google Scholar
• Eisberg N. Hard capsules—Soft centers. Manuf. Chem. 1981 December; 33–35
   Google Scholar
• Jones B.E. Practical advances in two-piece gelatin capsules. Manuf. Chem. 1987; 58: 27–31
   Google Scholar
• Somerville K.W., Richmond C.R., Bell G.D. Delayed release peppermint oil capsules (colpermin) for the spastic colon syndrome: a pharmacokinetic study. J. Clin. Pharmacol. 1984; 18: 638–640
   Web of Science ®Google Scholar
• Doelker C., Doelker E., Buri P., Waginaire L. The incorporation and in vitro release profiles of liquid, déliquescent or unstable drugs with fusible excipients in hard gelatin capsules. Drug. Dev. Ind. Pharm. 1986; 12: 1553–1565
   Web of Science ®Google Scholar
• Bowtle W.J., Baker N.J., Wodhams J. A new approach to vancomycin formulation using filling technology for semisolid matrix capsule. Pharma. Technol. 1988; 12: 86–97
   Google Scholar
• Naidoo N.T. Encapsulation and in vitro release of indomethacin from semi-solid matrix capsules. Int. J. Pharm. 1989; 55: 53–57
   Web of Science ®Google Scholar
• Baykara T., Yüksel N. The preparation of prolonged action formulation in the form of semisolid matrix into hard gelatin capsules of oxprenolol. I: thermocap method. Drug. Dev. Ind. Pharm. 1991; 17: 1215–1227
   Web of Science ®Google Scholar
• Shah V.P., Prasad V.K., Freeman C., Skelly J.P., Cabana B.E. Phenytoin II: in-vitro in-vivo bioequivalence standard for 100 mg phenytoin sodium capsules. J. Pharm. Sci. 1983; 72: 309–310
   PubMed Web of Science ®Google Scholar
• Sved V., Hossie R.D., McGilveray I.J., Beaudoin N., Brien R. Bioavailability, absorption and dissolution kinetics of phenytoin formulations. Can. J. Pharm. Sci. 1979; 14: 67–71
   Web of Science ®Google Scholar
• Suthisisang C., Payakachat N. Bioavailability of phenytoin sodium capsules available in Thailand. Part 1: in vitro study. J. Med. Assoc. Thai. 1998; 81: 58–63
   PubMedGoogle Scholar
• Suthisisang C., Payakachat N., Chulavatnatol S., Towarasbut S. Bioavailability of phenytoin sodium capsules available in Thailand. Part 2: in vivo study. J. Med. Assoc. Thai. 1998; 81: 64
   PubMedGoogle Scholar
• Abdallah O.Y., Ghaly G.M., El-Khordagui L.K., Naggar V.F., Khalil S.A. A study of the in-vitro availability of phenytoin from solid dosage forms marketed in Egypt. Alex J. Pharm. Sci. 1989; 3: 151–155
   Google Scholar
• Abdallah O.Y., Bedair K.H., Khalafallah N., Khalil S.A. Steady state plasma phenytoin levels in epileptic patients in relation to in vitro release data and clinical response. Alex J. Pharm. Sci. 1989; 3: 155–158
   Google Scholar
• Shafik A., El Massik M.A., Abdel Razek M., El Khordagui L.K., Khalil S.A. Study of the factors possibly involved in the fluctuation of in vitro performance of phenytoin sodium capsules. Alexandria Second International Conference of Pharmaceutical Sciences and Technology, AlexandriaEgypt, October, 2000
   Google Scholar
• Serajuddin A.T.M., Jarowski C.I. The influence of pH on release of phenytoin sodium from slow release dosage forms. J. Pharm. Sci. 1993; 82: 306–310
   PubMed Web of Science ®Google Scholar
• Ari-Ulubelen A., Akbuga G.J., Bayraktar-Alpmen G., Gulhan S. Effect of formulation factors on the in-vitro dissolution characteristics of phenytoin sodium capsules. Pharm. Ind. 1986; 48: 393–395
   Web of Science ®Google Scholar
• Rubino J.T., Halterlein L.M., Blanchard J. The effects of aging on the dissolution of phenytoin sodium capsule formulations. Int. J. Pharm. 1985; 26: 165
   Google Scholar
• Martin E.D., Frazer R.J.L., Camens I. Med. J. Aust. 1985; 143: 634–635
   PubMed Web of Science ®Google Scholar
• Cade D., Cole E.T., Mayer J.P., Walter F. Liquid filled and sealed hard gelatin capsules. Drug Dev. Ind. Pharm. 1986; 12: 2289–2300
   Web of Science ®Google Scholar
• , Gattefossé. Gelucire Pharmaceutical excipient for semisolid formulations filled into capsules; answering the need for enhanced bioavailability. Private paper, 1996
   Google Scholar
• Fantan J.E., Arnaud P., Chaumeil J.C. Enhancing properties of surfactants on the release from suppositories. Int. J. Pharm. 1991; 7: 17–23
   Google Scholar
• , W.H.O. Guidelines on Stability Testing of Pharmaceutical Products Containing Well Established Drug Substances in Conventional Dosage Form, 1994
   Google Scholar
• Dogenis G.A., Gold T.B., Shah V.P. Cross-linking of gelatin capsules and its relevance to their in vivo–in vitro performance. J. Pharm. Sci. 1994; 83: 915–921
   PubMed Web of Science ®Google Scholar
• Khalil S.A., Ali L.M.M., Abdel Khalek M.M. Effect of aging and relative humidity on drug release. Pharmazie 1974; 29: 36–37
   PubMed Web of Science ®Google Scholar
• Gouda H.W., Moustafa M.A., Al-Shora H.I. Effect of storage on nitrofurantoin solid dosage forms. Int. J. Parm. 1984; 18: 213–215
   Web of Science ®Google Scholar
• Murthy K.S., Enders N.A., Fawzi M.B. Dissolution stability of hard shell capsule products Part I: the effect of exaggerated storage conditions. Pharm. Technol. 1989; 13: 72–86
   Google Scholar
• Murthy K.S., Reisch R.G., Jr., Fawzi M.B. Dissolution stability of hard shell capsule products Part II: the effect of dissolution test conditions on the in vitro drug release. Pharm. Technol. 1989; 13: 53–58
   Google Scholar
• Dey M., Enever R., Kramel L., Prue D.G., Smith D., Weierstall R. The dissolution and bioavailability of etodolac from capsules exposed to conditions of high relative humidity and temperature. Pharm. Res. 1993; 10: 1295–1300
   PubMed Web of Science ®Google Scholar
• Yoshino H., Magiwara Y., Kobayashi M., Somijima M. Estimation of polymorphic transition degree in pharmaceutical raw materials. Chem. Pharm. Bull. 1984; 32: 1523–1526
   Web of Science ®Google Scholar
• Laine E., Auramo P., Kahela P. On the structural behaviour of triglycerides with time. Int. J. Pharm. 1988; 43: 241–247
   Web of Science ®Google Scholar